Edit search
Remarkable activity of novel agents bortezomib and thalidomi…
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
Article, Chapter
Authors: N.W. van de Donk
Publication: Volume:107, Issue:8, Page(s):3415-3416
Published: 2006
Browse related articles
  Request a copy of this item
Cite this item